Evidence map›Paper›PMID 29957106›Full record

ArticleAmerican journal of men's health2018

Depression and Prostate Cancer: Examining Comorbidity and Male-Specific Symptoms.

Simon M Rice, John L Oliffe, Mary T Kelly, Prue Cormie, Suzanne Chambers, John S Ogrodniczuk, David Kealy

Abstract read
In one paragraph

Article in American journal of men's health, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Prostate cancer biomarkers: from early diagnosis to precision treatment.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2024
    Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Promoting integrated care in prostate cancer through online prostate cancer-specific holistic needs assessment: a feasibility study in primary care.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2020
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Simon M Rice1 Orygen, The National Centre of Excellence in Youth Mental Health, Melbourne, Australia.
John L Oliffe3 School of Nursing, University of British Columbia, Vancouver, BC, Canada.
Mary T Kelly3 School of Nursing, University of British Columbia, Vancouver, BC, Canada.
Prue Cormie4 Mary Mackillop Institute for Health Research, Australian Catholic University, Melbourne, Australia.
Suzanne Chambers6 Cancer Research Centre, Cancer Council Queensland, Brisbane, Queensland, Australia.
John S Ogrodniczuk11 Department of Psychiatry, University of British Columbia, Vancouver, BC, Canada.
David Kealy11 Department of Psychiatry, University of British Columbia, Vancouver, BC, Canada.

Funding

Canadian Institutes of Health Research 11R06913
6 · The paper itself

Abstract

Depression in men with prostate cancer is a significant and complex issue that can challenge clinicians' diagnostic efforts. The objective of the current study was to evaluate prototypic and male-specific depression symptoms and suicidal ideation in men with a diagnosis of prostate cancer relative to those with and without comorbidity. The Patient Health Questionnaire-9 (PHQ-9) and Male Depression Risk Scale-22 (MDRS-22) were completed online along with demographic and background variables by 100 men with a diagnosis of prostate cancer ( n = 54 prostatectomy, n = 33 receiving active treatment). Hierarchical logistic regression was used to examine recent (past 2 weeks) suicide ideation. Over one-third of the sample (38%) reported a comorbidity, and this group had significantly higher total depression scores on the PHQ-9 (Cohen's d = 0.65), MDRS-22 emotion suppression ( d = 0.35), and drug use subscales ( d = 0.38) compared to respondents without comorbidity. A total of 14% reported recent suicidal ideation, of which 71.4% of cases were identified by the PHQ-9 "moderate" cut-off, and 85.7% of cases were identified by the MDRS-22 "elevated" cut-off. After control variables, MDRS-22 subscales accounted for 45.1% of variance in recent suicidal ideation. While limited by the exclusive use of self-report data, findings point to the potential benefits of evaluating male-specific symptoms as part of depression and suicide risk screening in men with prostate cancer and the need to be mindful of the heightened risk for depression among men with prostate cancer who have comorbidity.

Indexed as

AgedAged, 80 and overCanadaComorbidityDepressionHumansMaleMiddle AgedProstatic NeoplasmsPsychiatric Status Rating ScalesSuicidal Ideationcancerdepressiondepressive disordermen’s healthmental healthoncologyprostate cancer

Identifiers

PMID29957106
PMCPMC6199440

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.